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Abstract
Migration to Europe - and in particular the UK - has risen dramatically in the past decades, with implications for public
health services. Migrants have increased vulnerability to infectious diseases (70% of TB cases and 60% HIV cases are in
migrants) and face multiple barriers to healthcare. There is currently considerable debate as to the optimum approach to
infectious disease screening in this often hard-to-reach group, and an urgent need for innovative approaches. Little research
has focused on the specific experience of new migrants, nor sought their views on ways forward. We undertook a
qualitative semi-structured interview study of migrant community health-care leads representing dominant new migrant
groups in London, UK, to explore their views around barriers to screening, acceptability of screening, and innovative
approaches to screening for four key diseases (HIV, TB, hepatitis B, and hepatitis C). Participants unanimously agreed that
current screening models are not perceived to be widely accessible to new migrant communities. Dominant barriers that
discourage uptake of screening include disease-related stigma present in their own communities and services being
perceived as non-migrant friendly. New migrants are likely to be disproportionately affected by these barriers, with
implications for health status. Screening is certainly acceptable to new migrants, however, services need to be developed to
become more community-based, proactive, and to work more closely with community organisations; findings that mirror
the views of migrants and health-care providers in Europe and internationally. Awareness raising about the benefits of
screening within new migrant communities is critical. One innovative approach proposed by participants is a community-
based package of health screening combining all key diseases into one general health check-up, to lessen the associated
stigma. Further research is needed to develop evidence-based community-focused screening models - drawing on models
of best practice from other countries receiving high numbers of migrants.
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Introduction
With an estimated 72.6 million migrants now residing in
Europe, the region is an increasingly important recipient of
approximately one third of the international migrant population
[1,2]. In the past decade the UK in particular has received a
sizeable and increasing number of new migrants, which has had
important implications for public health services [3,4]. Infectious
diseases are believed to be the key health issue for new migrants
from high-prevalence countries, with asylum seekers and refugees
considered to be particularly affected [5]. Migrants bear the largest
burden of infectious disease in the UK; approximately 70% of
newly diagnosed UK tuberculosis (TB) and 60% of new HIV cases
are in migrants, with comparable trends expected for hepatitis B
and C [3,5–7]. London now has the highest tuberculosis rate
among all capital cities in western Europe [8]. Numerous factors
contribute to the vulnerability of new migrants to infectious
diseases, with migrants - and ethnic minorities more broadly -
known to face barriers to healthcare, which may result in delays to
screening and diagnosis [4,9]. Tackling infectious diseases may
raise specific issues, including stigma and fear of discrimination
[10–12]. New migrants may be particularly affected in terms of
their ability to access and benefit from screening programmes for
infectious disease as they attempt to navigate a new health system
[13,14].
How best to screen new migrants, and what to screen for,
remains an ongoing debate in the UK and Europe [15–20], with
approaches varying considerably [1,21,22]. The UK Government,
for example, has recently closed down its port of entry tuberculosis
screening because of concerns that it was poorly run, discrimina-
tory, and not cost-effective, opting instead for pre-entry screening.
Evidence suggests that it is critical to engage new migrants from
high-prevalence countries early on if they are planning to reside in
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the UK for a period of time. TB is known to surface 3–5 years
after arrival [6] and data suggests that HIV is often acquired in a
migrants’ home country with most unaware of their status on
arrival to the UK [23]. The issue of vaccination for infectious
diseases may also be important for health-care providers to
address. There have been calls to strengthen primary-care-based
screening programmes, and to place renewed focus on latent
tuberculosis screening to tackle the rising tide of tuberculosis
[17,18]. However, there remains a paucity of data on barriers to,
and acceptability of, screening programmes for infectious diseases
specifically in newly arrived migrants, and potential ways forward;
addressing these shortfalls remains an important component in the
strategy to tackle rising rates of infectious diseases.
We did a qualitative semi-structured interview study of migrant
community health-care leads, who represent dominant new
migrant groups in London, UK. The aim was to explore their
views around barriers, accessibility, and acceptability of screening
for HIV, tuberculosis, hepatitis B, and hepatitis C.
Methods
We did a series of semi-structured face-to-face interviews to
explore migrant community health-care leads’ perceptions about
(i) the barriers to screening for HIV, TB, and hepatitis B and C
faced by new migrants; (ii) acceptability of screening; and (iii)
innovative approaches to improve screening uptake in new
migrants. We defined new migrants as foreign-born individuals
who had resided in the UK for less than 5 years, arriving from
countries outside Western Europe, North America, Australia, and
New Zealand. Therefore, we sought information about new
migrant groups from high prevalence disease countries. We
carried out and reported this study using COREQ guidelines
[24] as well as the quality guidelines of Mays and Pope (2000) [25].
Figure 1. Interview topic guide.
doi:10.1371/journal.pone.0108261.g001
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The study was approved by the Imperial College Research Ethics
Committee.
Participant selection and recruitment
We approached migrant community health-care leads who
encompassed dominant groups of new migrants in the study site –
which was a high migrant area of West London (Hammersmith
and Fulham) where 42.8% of residents defined as foreign born
[26]. The inclusion criteria were community leads who were
expert professionals with a working knowledge of the health needs
of new migrants within the communities and nationality groups
they represented, who were .18 years of age, and capable of
giving informed consent. This approach – of recruiting community
leads rather than the new migrants themselves - is one used
successfully elsewhere, and was repeated with the aim of acquiring
an overview of the issues facing new migrants across a broad range
of nationality groups [27].
We recruited participants using purposive sampling to enable
exploration of particular aspects of behaviours relevant to the
research questions. We drew up a sampling frame for the target
population by carrying out internet searches of London-based
community groups around the study site. This list was used as a
starting point to generate a list of relevant individuals working
within these community groups who would meet study inclusion
criteria. Potential participants were then directly approached by
telephone and invited to participate. Those who were interested in
participating were emailed a Participant Information Leaflet about
the study, and re-contacted to confirm participation and arrange
the interview. Purposive sampling allowed us to then use our initial
participants to establish subsequent contact with other relevant
participants. Purposive sampling also allowed us to recruit a mix of
nationality groups to represent the major new migrant community
groups. We developed a topic guide (Figure 1) of both structured
and open questions based on previous work conducted by the
authors in collaboration with community leaders in another
London-base study site [27] and pilot tested it on the first
participant. Participant recruitment continued until data satura-
tion was achieved for all categories.
Data collection and analysis
In all but two cases, FS (female, British Asian) conducted
interviews at participants’ workplace in a private room where only
the interviewer and participant were present. FS had previously
been trained to conduct research interviews in the field of migrant
health. After acquiring written informed consent, participants
were reminded of the study aims and assured that all information
they shared would be confidential and presented in an anonymous
format, and the interview then commenced for 30–90 minutes.
The interviews were audio-recorded with permission (Sony
VOR Microcassette Recorder M-740V) and transcribed verbatim
for analysis by independent transcribers (anonymously) after each
interview. Case memos were made after every interview in
addition to theoretical memos to assist in the formulation of
theories. Data were analysed using the principles of grounded
theory, which involved systematically collecting and analysing data
simultaneously throughout the research process. Data were
managed using QSR NVivo 10 software.
Data was first coded by open coding to generate concepts. After
carrying out the first three interviews a list of all the codes elicited
from the transcripts were grouped into a list of categories using
axial coding. To guard against selectivity, two researchers (FS/SH)
independently conducted these processes and discussed the initial
interpretations of the data, the reliability of the codes, explanations
of particular codes, and additional areas for exploration within the
subsequent interviews. This discussion combined with the research
questions that shaped the topic guide formed the basis of the
Table 1. Characteristics of participants and the new migrants communities they represent.
Characteristics N
Participants 20
Gender of participants F (10), M (10)
Mean Age (range) 42.77 (25–64 years)
Mean years in the UK (range) 21.59 (4–43 years); 4 born in the UK
Country of birth Africa (8) – Kenya (1), Nigeria (3), Somalia (2), Uganda (1), Zambia (1)
Asia (3) – Bangladesh (1), Iran (1), Malaysia (1)
Europe (7) – Greece (1), Poland (1), Ukraine (1), United Kingdom (4)
Americas (2) – Colombia (1), Jamaica (1)
Nationalities of new migrants represented* Africa (13) – Algeria, Burkina Faso, Cameroon, Cote D’Ivoire, Egypt, Eritrea, Ethiopia, Ghana, Kenya, Morocco, Nigeria,
Senegal, Somalia, South Africa, Tunisia, Uganda, Zambia, Zimbabwe,
Americas (3) – Caribbean, Chile, Colombia, Ecuador, Venezuela,
Asia (9) – Bangladesh, China, India, Iraq, Iran, Lebanon, Nepal, Pakistan, Philippines, Syria,
Europe (3) – Latvia, Lithuania, Poland, Russia, Slovakia, Ukraine
Gender of new migrants represented Majority female (10), Majority male (5), Equal (5)
Age range of new migrants represented 20–85 years old
Citizenship status of new migrants
represented**
Claiming citizenship (11), EC citizen (5), Indefinite resident (2), Refugee or asylum seeker (14), Spouse visa (2), Student
visa (10), Tourist (1) Undocumented (3), UK citizen (5), Work permit (5), Unknown (2)
Level of English of new migrants represented A few words (9), Conversational (6), Fluent (5)
*Participants focussed on 39 different nationalities in total.
The numbers in brackets represent the number of participants who mentioned that the region is a majority that they represent.
**The numbers in brackets represent the number of participants who mention the status as one of the dominant statuses that they represent.
doi:10.1371/journal.pone.0108261.t001
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coding framework thereon. Transparency in the method and
regular checks and discussion about the codes and categories
mitigated experimenter bias.
A constant comparison approach was then used whereby
transcripts were reviewed and codes were developed in an iterative
process. By constantly comparing the codes and themes and using
deviant case analysis to explore conflicting views, we were able to
interpret the data with validity. As interviews were completed,
selective coding was conducted where the most common codes
and those seen as most revealing about the data were emphasised
and unified around a core framework. A final re-check of all
transcripts was carried out to check whether all text had been
accounted for and to ensure that all initial open-codes were
incorporated into each theme where appropriate. Member
checking was also adopted by sending the final report to all the
participants in the study for feedback.
Results
Sample characteristics
50 organisations working with migrants on health issues in the
survey site were identified from the initial internet search, of which
34 were unable to support us in identifying participants within
their own organisation (2 shut down; 5 contact details were out of
date; 19 did not respond; 4 could not identify potential participants
within their own organisation, 4 organisations declined). Of the
four organisations that declined participation: one only dealt with
more settled migrants who had been in the UK for long periods of
time; two stated that they did not have a health-care lead for an
interview; and one declined due to lack of experience in the field of
health care specifically.
From the initial contact with the remaining 16 organisations, 20
community health leads were identified and agreed to be
interviewed. By interview 20, data saturation was achieved, no
new or relevant material arose, and it was highly probably that
additional interviews would not have influenced results. There
were an equal number of male and female participants (mean age
42.7 years). Nine participants worked in HIV & AIDS related
organisations, one in a TB related organisation, and one in a
hepatitis B related organisation; 16 of 20 were migrants themselves
and of the remaining, 3 out of 4 were from ethnic minority groups
in the UK. Five participants were Chief Executives/Directors of
the organisations they represented, 5 were programme coordina-
tors, 2 were project leaders, 3 were project managers, 2 were
Table 2. Barriers to screening reported.
Level Barrier
System and provider level barriers Capacity/funding shortages for community organisations
Lack of advocacy and promotion
Lack of confidentiality
Lack of psycho-social support services
Low awareness of diseases amongst health professionals
Poor link with community organisations
Migrant unfriendly services
Discrimination and stigma from health professionals
Cultural insensitivity
Inhospitality
Time and distance to services
Community level barriers Culture
Cultural mentality and baggage
Extra pressure for women regarding virginity and family role
Lack of openness
No prevention culture
Faith, lack of openness, and stigma
Language
Stigma and misconceptions
Patient level barriers Fear of a lack of confidentiality
Fear of cost and eligibility (perceived or actual)
Fear of disease status
Isolation
Lack of awareness and knowledge of diseases
Lack of confidence using new health system
Lack of screening services or health-system knowledge
Misunderstanding between health system in current residence vs country of origin
Low perception of risk
Low priority on immigrant list
Poorer health-seeking behaviour in men
doi:10.1371/journal.pone.0108261.t002
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community development officers, 1 was a project officer, 1 was a
volunteer, and 1 was a faith engager. Participants represented new
migrant communities from 39 diverse nationalities across Africa,
Americas, Asia and Europe (age range in these communities 20–
85 years). The majority of new migrants represented were refugees
and asylum seekers, followed by migrants claiming citizenship, and
those on student visas; most of the population under discussion,
therefore, were considered by participants to be of low socioeco-
nomic status (Table 1).
Key themes
Two key themes emerged from the interviews:
(i) Existing screening models are not perceived to be widely
accessible to the new migrant community. The main barriers
that discourage use are disease-related stigma present in their
own communities and services being perceived as non-
migrant friendly. New migrants may be disproportionately
affected and delays to screening may impact on health status.
(ii) Screening is certainly acceptable to new migrants. Partici-
pants stressed the need for service providers to bring
accessible and migrant-friendly screening into the communi-
ty, strengthening collaborations with community-based
organisations, and proposed a community-based package of
health screening combining all of the diseases into one
general health check-up with the aim of reducing stigma.
The barriers and facilitators described were points most
commonly recommended or strongly recommended by partici-
pants.
Screening is inaccessible to the new migrant community
Participants identified a range of barriers to screening for
infectious diseases at the health system, community, and individual
level (Table 2). There was strong agreement among participants
that screening for infectious diseases was not accessible to the new
migrant community in the UK. Most participants felt that
although screening services do exist, they are not adequately
reaching people in the community, stating that ‘‘people don’t even
know that these [screening services] exist’’ (Participant 11, age 31,
male, Latin American community) and that new migrants
specifically ‘‘do not easily take them up’’ (Participant 1, age 52,
male, African community). Some participants added that the
services are not well-publicised as information on them is not given
to new migrants who are attempting to navigate a new health
system, while one participant believed that services at present are
‘‘not pro-active’’ in encouraging new migrants to come forward for
testing, and focus remains too much on the ‘‘treatment angle’’
rather than a preventative approach (Participant 13, age 32, male,
migrant communities).
The most cited barrier, highlighted by 19 of 20 participants, was
the stigma and misconceptions that new migrant communities’
hold about the key diseases. Participants identified that stigma
within their own communities is the ‘‘biggest barrier to date’’ and
the ‘‘biggest dilemma’’ they face when considering going for
screening. Each disease has more than one different type of stigma
in the different communities. According to participants, we found
that TB, HIV, and hepatitis B and C can be perceived by new
migrant communities as being ‘‘fatal’’ and/or ‘‘highly infectious’’,
which generates fear of testing. As a result of stigma, new migrants
may ‘‘run-away’’ from the infected individuals, not inviting
infected individuals to their houses, eating with them, or wanting
to be near them. Participants said this discourages people from
attending screening, because they may have to face such disease-
related social consequences if people know they have attended
screening and an infection is found. TB specifically is perceived in
the Somali and Asian community as a ‘‘disease of the poor’’ and in
the Asian community also as ‘‘hereditary’’.
Participants unanimously considered HIV to still be the most
stigmatised disease of the four. Issues around stigma for HIV are
complex and deeply interlinked with a migrant’s culture and faith.
Stemming from cultural and religious beliefs, HIV is perceived as
a result of a ‘‘sinful’’ and ‘‘immoral’’ lifestyle including ‘‘pre-
marital sex’’, ‘‘drug use’’, ‘‘promiscuity’’, or ‘‘being gay’’.
Participants said that new migrant communities see HIV as being
self-inflicted, a ‘‘punishment from God’’ and a ‘‘well-deserved
disease’’. This prevents people from attending screening ‘‘as
nobody wants to be seen in that way’’ (Participant 5, age 59, male,
Somali community). Two participants also indicated that in the
African migrant community, HIV is strongly associated with TB.
Therefore, people often misconceive patients who have TB as
having HIV or vice versa. Little was known about hepatitis stigma
and only three participants indicated that the stigma could be
similar to the way in which HIV is perceived, ‘‘filled with things
about a lifestyle, moral behaviour and stereotypical things’’
(Participant 2, age 44, male, Ukrainian community).
The second most important barrier reported by participants was
that the screening services are not ‘‘migrant friendly’’. Twelve
Figure 2. Case study on the consequences of the barriers to screening.
doi:10.1371/journal.pone.0108261.g002
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participants expressed concerns about the cultural insensitivity
experienced by new migrants within services, where sometimes
assumptions are made about the patients. In addition to cultural
insensitivity, eight participants indicated that new migrants were
frustrated with the inhospitable and unfriendly experiences when
they accessed services. Many of these participants were concerned
with the inhospitality of receptionist staff in particular; one
participant said that this was the case even where receptionists
were from an ethnic minority or migrant background themselves.
In addition, seven participants identified discrimination from
health-care professionals as an important barrier. Some partici-
pants mentioned that the discrimination was against the new
migrants’ country of origin, for example one participant who went
to ask for results was asked by a nurse, ‘‘Is this the way you guys
behave in Africa?’’ (Participant 13, male, age 32, all migrant
communities), while another participant reported patients being
asked: ‘‘why don’t you speak English, how long have you been
here?’’ (Participant 20, age 36, female, all migrant communities).
Language barriers may be a particular issue for new migrants on
arrival; most new migrants represented in this study spoke little
English (Table 1). Another participant identified that it was a
combination of their migrant status, as well as their infectious
disease, that lead to discrimination. Four participants, however,
felt that services were culturally sensitive and had not come across
any cases or complaints from within their communities.
Participants also mentioned a number of barriers that may be
unique to new migrants, including the issue of a lack of entitlement
to free health care and confidentiality issues (table 2). Participants
commented that new migrants ‘‘have to find their own way’’
(Participant 5, age59, male, Somali community), that ‘‘they don’t
know what exists…that they have the right, that it’s free’’
(Participant 11, age 31, male, Latin American community). New
migrants ‘‘may not think they’re entitled to help here and they
may not think they could just go and get it’’ (participant 15, age
48, male, African community). New migrants may also have
confidentiality issues ‘‘concerns around immigration’’ and whether
their ‘‘disease status will be shared with immigration services’’
(Participant 12, age 27, male, Afro-Caribbean community).
Participants report that new migrants are concerned that clinical
services, especially in hospital settings, are ‘‘government bodies
and attached to the government…therefore somehow linked to
immigration’’ (Participant 10, male, age 29, Asian community). In
particular, some new migrants perhaps ‘‘don’t have a visa’’ and are
scared of ‘‘exposing themselves’’ by attending screening as ‘‘they
will be deported because of their status’’ (Participant 18, age 59,
female, African community).
Barriers to care have implications for health status
Participants highlighted a number of consequences that barriers
can have for a new migrant patient and the wider community.
Directly, the barriers stopped migrants from attending screening
services as they ‘‘wait until their situation has got a little bit worse,
when it’s actually disabling them and they can’t do any other
activities’’ (Participant 14, age 40, male, African community)
before they get tested for the diseases. ‘‘When they are screened
later then the medication is not given the optimum chance to work
for them…then obviously they have got a very narrow chance of
recovery’’ (Participant 1, age 52, male, African community). Four
participants mentioned that this ‘‘late diagnosis’’ has led to cases of
death in their communities; a case study from one participant is
presented in Figure 2.
Two participants mentioned that in the Eastern European
community new migrants may turn to alternative forms of
medication, for example, getting ‘‘herbs sent back from home’’
(Participant 2, age 44, male, Ukrainian community), ‘‘return back
home’’ (Participant 7, age 31, female, Eastern European
community) to do the screening or may also use services from
individuals in the community ‘‘who they knew practiced medicine
back in their own country’’ but who are not yet licensed in the UK
(Participant 2, age 44, male, Ukrainian community). At the
community level, participants raised concerns that by presenting
late and not knowing ones status, new migrants with infections
may be ‘‘putting others at risk’’ and increasing ‘‘the number of
people being exposed to that risk’’ (Participant 6, age 34, female,
Arabic speaking community).
How do we improve access to screening?
Despite this lack of accessibility there was consensus among
participants that screening is acceptable to new migrants, if
services are promoted and offered in a tailored and sensitive
manner, and uptake would be high if barriers were broken down.
Participants collectively reported that between 50% and 100% of
new migrants they represented would consider screening if it was
more accessible to them. One participant mentioned that ‘‘in
Table 3. Approaches identified to make screening more accessible.
Approach
Better access features
Build migrants confidence to access health services
Engage faith-based organisations
Ensure confidentiality
Improve hospitality and cultural sensitivity, through educating front-line staff on cultural competencies and migrant health needs
Increase language support
Increase psycho-social support
More appropriate and accessible promotion of screening
Offer one package of care for migrants, a general health check incorporating infectious disease screening
Outreach for isolated migrants
Raise awareness of diseases and screening in communities
Stronger collaboration with community organisations
doi:10.1371/journal.pone.0108261.t003
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relation to their health they [the community] wouldn’t hesitate to
take part in the screening….because it’s for their benefit.’’
(Participant 6, age 34, female, Arabic speaking community).
Key factors to consider when making screening more accessible
included ensuring better collaboration between service providers
and community organisations, as well as combining the screening
of diseases into one appointment (table 3). Whether with faith-
based or nationality based organisations, all participants strongly
conveyed the message that screening services need to be taken out
into the community and that the health service must work in
partnership with community organisations. Community organisa-
tions are a key ‘‘asset’’ because they have the link to the migrant
communities and hard-to-reach individuals (Participant 13, age
32, male, migrant communities). Interventions should be ‘‘co-
owned’’ and based on the ‘‘principles of partnership about
coexistence, collaboration, and cooperation’’ (Participant 13, age
32, male, all migrant communities) if screening services are to be
made more accessible. Statutory service providers should focus on
raising awareness of diseases, promotion of screening services,
language and psycho-social support, as well as designing services
that are migrant friendly and culturally sensitive with input from
community organisations.
Most of the participants argued that screening services need to
be taken out of the hospital and into the community to make
access easy, ’’not sticking into one building or geographical
location’’ (Participant 13, age 32, male, all migrant communities)
and ‘‘delivering the service to the people where they are’’
(Participant 15, age 48, male, African community). Participants
identified community settings such as places of worship, football
games, community centre events, and carnivals as good opportu-
nities to run screening interventions. As one participant explained,
there is a bus outside the local market where - with the assistance
of community health workers - individuals can ‘‘go in there, get
fully screened, come back to the market and buy your goat meat
and your plantain and go home knowing your status’’ (Participant
15, age 48, male, African community). Another participant made
the point that people would prefer screening at the site of a
community organisation, compared to a hospital, as they would
feel more ‘‘comfortable’’ having attended the organisation before,
and that these organisations have ‘‘staff employed from the
community itself, when people come they may have a worker on
hand who can talk them through the process in a culturally
sensitive manner, or in a linguistically sensitive manner’’
(Participant 10, male, age 29, Asian community). By bringing
screening into communities screening programmes will ‘‘work
better and be far more effective’’ (Participant 15, age 48, male,
African community).
15 of 20 participants considered that the best approach is to
offer new migrants a package of care to include screening for TB,
HIV, and hepatitis B and C at one appointment; the majority
supported the idea of this being within a community setting.
Participants suggested that screening be advertised as a general
‘‘health check’’ which would make migrants more receptive and
considerably lessen the stigma of infectious diseases. Most
importantly, participants felt that offering screening for multiple
diseases at one appointment would lessen the dominant barrier of
stigma that can prevent migrants from attending screening. This
approach could be ‘‘immensely convenient for the person as well
as the service’’ (Participant 15, age 48, male, African community).
Participants suggested that packaging screening in this integrated
way will reduce stigma, or ‘‘push stigma down’’ (Participant 13,
age 32, male, all migrant communities) and participants would say
yes to screening as it ‘‘is enough for people to take a minute and
think okay, I know for a fact that I might not have HIV but I
might well have the others’’ (Participant 6, age 34, female, Arabic
speaking community).
Discussion
This research highlighted strong agreement among health-care
leads that screening for infectious diseases is currently inaccessible
to the new migrant community in the UK. Interestingly, a key
factor in poor uptake rate among the new migrant community was
stigma and misconceptions that new migrant communities’
themselves hold about the key diseases, deeply interlinked with a
migrants’ culture and faith, as well as perceived fears around the
social implications of attending screening and receiving a positive
diagnosis. Participants identified numerous barriers to accessing
screening services at the current time - which were considered to
be non-migrant friendly and culturally insensitive. New migrants
are likely to be disproportionally affected by these barriers, and
delays to diagnosis and treatment may have health consequences.
However, there was strong consensus that acceptability of
screening of the four key diseases is high among new migrants.
Participants stressed the need to bring accessible and proactive
screening into the community, strengthening collaborations with
community-based organisations. They supported the idea of a
community-based package of health screening combining all of the
diseases into a general health check-up, with the aim of lessening
the associated stigma.
We are aware that the views expressed by participants will
reflect their own experiences of working with the health system
around West London. While this may impact on the responses
they provided, as community leads, their primary role is to
represent their communities. We encouraged interviewees to talk
about the wider communities around them; nevertheless, it is a
challenge to have one group of people speak for another, and a
separate study exploring the specific views of different groups of
new migrants will be of interest. In addition, we are aware that a
considerable number of participants were working in HIV as
oppose to other infectious diseases under discussion, which will
mean there may be an inevitable focus on barriers as they relate to
HIV services.
Data are limited on the issue of infectious disease screening
specifically in the new migrant community; however, numerous
studies exist on the use of general health services by the wider
migrant community and ethnic minority groups which confirm a
myriad of potential barriers to access that confer with our findings
[27–29]. Studies specifically exploring HIV testing barriers in
migrants, including a systematic review [30] overlap with our
findings in new migrants across all four diseases – including
migrants having insufficient information about diseases and their
prevention, lack of knowledge about health service provision, a
perceived discriminatory attitude of health-care providers (includ-
ing reception staff), fear of a lack of confidentiality and
deportation, and confusion over entitlement to free health care
[31–33]. Furthermore, studies on tuberculosis in ‘‘vulnerable
groups’’ report that a key barrier to screening was to do with
concerns around stigma within their own communities, and a fear
of death [34–36]. For hepatitis B and C, previous studies in
migrants and ethnic-minority groups report barriers related to
language and culture, discrimination and stigma, low confidence
in health services, lack of knowledge of available services,
association of hepatitis testing with sexual health, and a low
perception of disease risk [12,37,38]. What is clear is that the data
themes we have documented are not unique to new migrants, but
common experiences of migrant and ethnic minority groups
affected by these diseases. However, it is our view that new
Screening Migrants for Infectious Diseases
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migrants who are attempting to navigate a new health system and
settle in a new community are likely to be disproportionally
affected. That barriers to health care among new migrants may
impact on health status has been previously reported [27,33]. That
acceptability for screening of HIV, TB, and hepatitis B and C is
high among migrants has also been reported elsewhere, with
migrants considered to be proactive about their health and
screening ‘‘valued highly’’ [39,40].
We found that there was a unanimous view among participants
that to facilitate greater uptake of testing screening must be
brought into the community, with service providers strengthening
collaborations with community-based organisations. In the UK
and elsewhere there are interesting examples of successful
community outreach screening initiatives that target migrants for
TB, HIV, or hepatitis (Table 4); however literature on commu-
nity-based approaches are scarce with few high quality or
controlled studies evaluating community models. We have found
that data from innovative locally tested screening initiatives are
often not published so the benefits of these approaches remain
unclear. Conversely, international studies have reported unsuc-
cessful community-based collaborations, in terms of uptake [41]
and cost-effectiveness [42]. The Migrant-Friendly Hospitals
Initiative, which resulted in The Amsterdam Declaration (To-
wards Migrant-Friendly Hospitals in an Ethno-culturally diverse
Europe) in 2004, specifically calls for service providers to focus on
developing partnerships with local community-based organisations
with a view to improving service delivery to migrant groups [43].
Screening high risk groups for TB in General Practice/primary
care has been formally assessed in a randomised controlled trial
and found to be successful in terms of increased yield [44]. The
optimum approach in high-migrant receiving countries is most
likely to offer screening in a range of settings [39,45], incorporat-
ing a strong focus on community engagement and partnership
with migrant organisations in both the design and implementation
of screening approaches.
The idea raised by participants of combining these diseases into
some kind of general health check-up, with the aim of reducing the
considerable stigma associated with infectious diseases, merits
further exploration. Such an approach will need to be combined
with awareness raising about the benefits of screening within new
migrant communities, and attempts to facilitate high uptake to
services, in an attempt to tackle misconceptions and reduce stigma.
The UK’s Health Protection Agency previously recommended
that consideration be given to the idea of an extended New Patient
Health Check for certain groups of migrants in primary care [6].
To what extent such an approach can be adopted in other high-
migrant receiving countries is unknown, with countries taking a
wide variety of approaches to screening for infectious diseases in
this patient group [22]. Further research is now urgently needed to
develop evidence-based community-focussed screening models -
drawing on models of best practice and lessons learned from UK
and internationally – as well as exploring how healthcare
professionals can work more effectively with the new migrant
community to facilitate improved access to screening.
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Table 4. Examples of international models of community-based migrant screening collaborations for TB, HIV or hepatitis B and C.
Study Model
Jafferbuoy et al. Scotland, UK [46] Mosque and Islamic centre based screening
Raised awareness and promoted screening for hepatitis B and C in the mosque. After raising awareness, community
offered screening in the mosque one day a week.
High uptake: 177/250 attendees coming forward for testing in the mosques
Only a modest investment in staff time.
Sadler et al. London, UK [47] Various community settings - bars, health promotion events, community centre and social gatherings
Conducted a survey of sexual attitudes in addition to HIV test.
High uptake: 94/114 took test
Lewis et al. UK [48] Mosque based screening promotion
Distributed 5000 viral hepatitis testing cards in Mosques, following an awareness campaign, encouraging viral
hepatitis testing at GP surgery.
Community awareness campaigns and leaflets do not directly lead to testing for viral hepatitis
Gany et al. New York, USA [49] Airport holding lot
Conducted TB counselling and screening for taxi drivers in the airport holding lot - drivers drove through the lane,
placed their arms out for measurement of the tuberculin skin test reaction. 123 drivers who participated, two thirds
(82) were at high risk for tuberculosis. Seventy-eight (63%) of the 123 returned for test readings.
Brassard et al. Montreal, Canada [50] School-based screening
Newly arrived immigrant children in selected schools were screened for latent TB. Family and household associates
of the TST-positive child also were screened for LTBI. 542/2524 (21%) were TST-positive. Of 342 children started on
therapy, 316 (92%) demonstrated adequate adherence. 599 associates investigated from the 484 TST-positive
schoolchildren seen at the TB clinic. Of 555 associates with TST results, 211 (38%) were found to be TST-positive.
Programme was effective and cost-effective.
doi:10.1371/journal.pone.0108261.t004
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